Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA (FRE)

Market Open
20 Jun, 20:00
41. 94
+0.31
+0.74%
- Market Cap
41.66 P/E Ratio
0.67% Div Yield
12 Volume
2.9 Eps
41.63
Previous Close
Day Range
41.65 41.98
Year Range
27.87 44.31
Want to track FRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 44 days

Summary

FRE trading today higher at €41.94, an increase of 0.74% from yesterday's close, completing a monthly decrease of -2.51% or €1.08. Over the past 12 months, FRE stock gained 25.61%.
FRE is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.02%, based on the last three reports. The next scheduled earnings report is due on Aug 06, 2025.
Fresenius SE & Co. KGaA has completed 1 stock splits, with the recent split occurring on Aug 04, 2014.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on XWBO (EUR).

FRE Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

Fresenius SE & Co. KGaA (FRE) FAQ

What is the stock price today?

The current price is €41.94.

On which exchange is it traded?

Fresenius SE & Co. KGaA is listed on XWBO.

What is its stock symbol?

The ticker symbol is FRE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Aug 06, 2025.

Has Fresenius SE & Co. KGaA ever had a stock split?

Fresenius SE & Co. KGaA had 1 splits and the recent split was on Aug 04, 2014.

Fresenius SE & Co. KGaA Profile

Medical Care Facilities Industry
Healthcare Sector
Mr. Michael Sen CEO
XMUN Exchange
- ISIN
Germany Country
177,091 Employees
23 Aug 1970 Last Dividend
- Last Split
- IPO Date

Overview

Fresenius SE & Co. KGaA is a leading health care company specializing in providing a wide range of products and services for chronically ill patients. With its operations divided into four primary segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed, the company caters to the varied needs of patients worldwide. Fresenius Medical Care focuses on offering solutions for those suffering from chronic kidney failure, while Fresenius Kabi is dedicated to the therapy and care of critically and chronically ill patients through its range of drugs, nutrition products, and medical technologies. Fresenius Helios operates clinical and nursing care facilities, and Fresenius Vamed delivers services for hospitals and other healthcare facilities, including operational management. Established in 1912 and formerly known as Fresenius SE, the company underwent a name change in January 2011 to Fresenius SE & Co. KGaA. Headquartered in Bad Homburg vor der Höhe, Germany, Fresenius stands as a testament to innovation and dedication in the healthcare sector.

Products and Services

  • Fresenius Medical Care: Focuses on patients with chronic kidney failure, offering dialysis machines, dialyzers, related disposable products, and dialysis-related services. This comprehensive range is designed to improve the quality of life for patients undergoing dialysis treatment.
  • Fresenius Kabi: Specializes in the care of critically and chronically ill patients by providing:
    • I.V. Generic Drugs: A variety of intravenous generic medications tailored to meet the needs of patients and healthcare providers.
    • Biosimilar Drugs: Treatments for autoimmune diseases and oncology, offering cost-effective alternatives to biologic drugs while maintaining quality and efficacy.
    • Enteral and Parenteral Nutrition Products: Essential nutrition solutions for patients who cannot eat normally, ensuring they receive the necessary nutrients.
    • Medical Technologies and Disposables: Including infusion pumps, apheresis machines, and cell therapy devices, supporting advanced patient care.
  • Fresenius Helios: Provides clinical and nursing care facilities, ensuring high-quality care and services for patients and facilitating a holistic approach to health recovery and management.
  • Fresenius Vamed: Offers services for hospitals and other healthcare facilities ranging from operational management to comprehensive care services, aimed at optimizing healthcare delivery and patient experience.

Contact Information

Address: Else-Kroener-Strasse 1
Phone: 49 6172 6080